#pharmaceutical regulation
2 stories

U.S. signals openness to Chinese drug deals
American regulators may allow pharmaceutical licensing with China while restricting AI and semiconductors.
CNBC · 1m
India moves to centralize sterile drug oversight
A proposal would bring all sterile medicines under central licensing to address contamination risks and regulatory fragmentation.
The Economic Times · 1m